Switch to:
More From Other Websites
What’s behind the Recent Fall in Alexion’s Valuation Multiple? Jul 25 2016
How Much Will Orkambi Fetch for Vertex Pharmaceuticals in 2Q16? Jul 22 2016
How Can Alexion Stay ahead of the Competition with Soliris? Jul 22 2016
ALNY Should Complete Revusiran’s Endeavour Trial Enrollment in Late 2016 Jul 14 2016
Biotech ETFs: Will the Once Hot Group Rebound? Jul 13 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK